TABLE 4.

Oligonucleotides used in this study

Purpose and designation	Sequence (5′–3′)
Cloning
Vr-pWSK 29-2	GGTACCCAATTCGCCCTATAGTGAGTCGTATTAC
Vf-16-2	GGCTCTGCGGCGTCTGCGGCGGGC
Vf-L16	GGCTCTGCGGCGTCTGCG
Vr-p2643	TGGTTCTCCCCGAGATGT
Vr effector HA	TTAAGCGTAGTCTGGGACGTCGTATGGGTACTCC
1f-sseF-L16	ACATCTCGGGGAGAACCAGGCTCTGCGGCGTCTGCG
1f-sifA	TAGGGCGAATTGGGTACCAGGTGAGTGATATAAGCGATTAATTGC
1r-sifA	CGCAGACGCCGCAGAGCCTAAAAAACAACATAAACAGCCGCTTT
1f-sseJ	TAGGGCGAATTGGGTACCTTAATATGAAAATAGAAATCAAAATGTCACATAA
1r-sseJ	CGCAGACGCCGCAGAGCCTTCAGTG-GAATAATGATGAGCTA
1f-pipB2	TAGGGCGAATTGGGTACCTAATAAAATGCCTGAACACG
1r-pipB2	CGCAGACGCCGCAGAGCCAATATTTTCACTATAAAATTCGTTAAAG
1f-sipA-L16	GGCTTGCACATGCAGCGTGGCTCTGCGGCGTCTGCG
1f-sopB-L16	AGGCATTTCTTCATTAATCACATCTGGCTCTGCGGCGTCTGCG
Vr-p4040	ACGCTGCATGTGCAAGCC
Vr-p4042	AGATGTGATTAATGAAGAAATGCCTTT
Vr-p4043	GGGAGTGTTTTGTATATATTTATTAGCAATGT
1r-SNAP_CLIP-HA	TGGGACGTCGTATGGGTAACCCAGCCCAGGCTTGCC
Vf-HA	TACCCATACGACGTCCCAGA
Sequencing
HaloTag-Check-Rev	TGGAAAGCCAGTACCGATTT
SnapTag-Check-Rev	CTTCATTTCGCAGTCTTTGT
Seq-For	CGCCAGGGTTTTCCCAGTCACGAC